This company has been marked as potentially delisted and may not be actively trading. ImmunoGen (IMGN) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock IMGN Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Entero Therapeutics Amends Rescission Agreement with ImmunogenXJuly 16 at 5:26 PM | tipranks.comBPDCN Market Set for Robust Growth Through 2032 Driven by Targeted Therapies and Rising Disease Awareness | DelveInsightApril 15, 2025 | theglobeandmail.comAbbVie's SWOT analysis: stock outlook strong despite humira lossFebruary 4, 2025 | msn.comAntibody Drug Conjugates Market Size is Expected to Reach USD 25.38 Billion by 2033, Growing at a CAGR of 8.84%: Straits ResearchJanuary 22, 2025 | globenewswire.comPureTech Founded Entity Seaport Therapeutics Names Lauren White as Chief Financial OfficerNovember 5, 2024 | finance.yahoo.comSeaport Therapeutics Names Lauren White as Chief Financial OfficerNovember 5, 2024 | finance.yahoo.comArtisan International Small-Mid InstlOctober 25, 2024 | morningstar.comMArtisan International Small-Mid AdvisorOctober 25, 2024 | morningstar.comMPolaris Global Equity Composite Q1 2024 CommentaryApril 25, 2024 | seekingalpha.comLazard posts first-quarter profit on deals, assets boostApril 25, 2024 | investing.com3 Potential Biopharma Buyout TargetsApril 23, 2024 | seekingalpha.comAbbVie Gets Full OK For Cancer Drug Acquired in ImmunoGen DealMarch 22, 2024 | marketwatch.comFred Alger Management LLC Purchases 316,201 Shares of ImmunoGen, Inc. (NASDAQ:IMGN)March 1, 2024 | marketbeat.comFmr LLC Has $91.86 Million Position in ImmunoGen, Inc. (NASDAQ:IMGN)February 28, 2024 | marketbeat.comAbbVie plans to offer senior notes to fund Immunogen, Cerevel dealsFebruary 21, 2024 | msn.comCERE Aug 2024 30.000 callFebruary 19, 2024 | ca.finance.yahoo.comRafferty Asset Management LLC Acquires 229,699 Shares of ImmunoGen, Inc. (NASDAQ:IMGN)February 18, 2024 | marketbeat.comState of New Jersey Common Pension Fund D Cuts Stock Position in ImmunoGen, Inc. (NASDAQ:IMGN)February 17, 2024 | marketbeat.comSkandinaviska Enskilda Banken AB publ Invests $769,000 in ImmunoGen, Inc. (NASDAQ:IMGN)February 16, 2024 | marketbeat.comRhenman & Partners Asset Management AB Sells 571,716 Shares of ImmunoGen, Inc. (NASDAQ:IMGN)February 12, 2024 | marketbeat.comBarclays Keeps Their Hold Rating on ImmunoGen (IMGN)February 12, 2024 | markets.businessinsider.comAbbVie revises Q1 earnings outlook as ImmunoGen deal closesFebruary 12, 2024 | msn.comImmunoGen (Nasdaq:IMGN) HeadlineTrading was temporarily halted for "IMGN" at 07:02 PM with a stated reason of "News pending."...February 12, 2024 | marketbeat.comBarclays PLC Boosts Stake in ImmunoGen, Inc. (NASDAQ:IMGN)February 10, 2024 | marketbeat.comImmunoGen (NASDAQ:IMGN) Sees Strong Trading VolumeFebruary 9, 2024 | marketbeat.comIs ImmunoGen (IMGN) Outperforming Other Medical Stocks This Year?February 9, 2024 | finance.yahoo.comFinal Countdown: AbbVie's Imminent Closure With ImmunoGen And What It MeansFebruary 9, 2024 | seekingalpha.comImmunoGen Set to Merge with AbbVie, Awaiting Final ApprovalFebruary 9, 2024 | msn.comImmunoGen (IMGN) Soars 5.7%: Is Further Upside Left in the Stock?February 9, 2024 | finance.yahoo.comImmunoGen (NASDAQ:IMGN) Hits New 52-Week High at $31.24February 8, 2024 | marketbeat.comJump Financial LLC Lowers Holdings in ImmunoGen, Inc. (NASDAQ:IMGN)February 3, 2024 | marketbeat.comMoody Aldrich Partners LLC Has $4.51 Million Stock Holdings in ImmunoGen, Inc. (NASDAQ:IMGN)February 2, 2024 | marketbeat.comImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)February 2, 2024 | finance.yahoo.comBrokers Set Expectations for ImmunoGen, Inc.'s Q4 2024 Earnings (NASDAQ:IMGN)February 2, 2024 | marketbeat.comImmunoGen, Inc. (IMGN) Interactive Stock Chart - Yahoo FinanceFebruary 2, 2024 | finance.yahoo.comFY2023 Earnings Estimate for ImmunoGen, Inc. (NASDAQ:IMGN) Issued By Zacks ResearchFebruary 1, 2024 | marketbeat.comAlpha DNA Investment Management LLC Purchases New Shares in ImmunoGen, Inc. (NASDAQ:IMGN)January 31, 2024 | marketbeat.comRaymond James & Associates Buys 150,652 Shares of ImmunoGen, Inc. (NASDAQ:IMGN)January 23, 2024 | marketbeat.comStrs Ohio Reduces Stake in ImmunoGen, Inc. (NASDAQ:IMGN)January 21, 2024 | marketbeat.comLord Abbett & CO. LLC Reduces Stock Holdings in ImmunoGen, Inc. (NASDAQ:IMGN)January 20, 2024 | marketbeat.comBank of New York Mellon Corp Boosts Stock Position in ImmunoGen, Inc. (NASDAQ:IMGN)January 19, 2024 | marketbeat.comInsider Selling: ImmunoGen, Inc. (NASDAQ:IMGN) SVP Sells 187,667 Shares of StockJanuary 18, 2024 | marketbeat.comTD Asset Management Inc Purchases 184,500 Shares of ImmunoGen, Inc. (NASDAQ:IMGN)January 18, 2024 | marketbeat.comImmunoGen, Inc. (NASDAQ:IMGN) Sees Significant Increase in Short InterestJanuary 15, 2024 | marketbeat.comEmerald Mutual Fund Advisers Trust Has $23.27 Million Holdings in ImmunoGen, Inc. (NASDAQ:IMGN)January 9, 2024 | marketbeat.comHow ImmunoGen (IMGN) Stock Stands Out in a Strong IndustryJanuary 9, 2024 | finance.yahoo.comEmerald Advisers LLC Purchases 827,609 Shares of ImmunoGen, Inc. (NASDAQ:IMGN)January 8, 2024 | marketbeat.comImmunoGen, Inc. (NASDAQ:IMGN) Receives Average Rating of "Hold" from BrokeragesJanuary 8, 2024 | marketbeat.comIMGN Quantitative Stock AnalysisJanuary 4, 2024 | nasdaq.comAll You Need to Know About ImmunoGen (IMGN) Rating Upgrade to Strong BuyJanuary 4, 2024 | msn.com Get ImmunoGen News Delivered to You Automatically Sign up to receive the latest news and ratings for IMGN and its competitors with MarketBeat's FREE daily newsletter. Email Address IMGN Media Mentions By Week IMGN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IMGN News Sentiment▼0.000.96▲Average Medical News Sentiment IMGN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IMGN Articles This Week▼10▲IMGN Articles Average Week Get ImmunoGen News Delivered to You Automatically Sign up to receive the latest news and ratings for IMGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BIIB News Today INCY News Today UTHR News Today NBIX News Today EXEL News Today BMRN News Today EXAS News Today HALO News Today MDGL News Today RGEN News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IMGN) was last updated on 7/18/2025 by MarketBeat.com Staff From Our Partners[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredFREE BUY ALERT: These 3 tiny AI stocks could surgeWe're living in unprecedented times. Most people think it's too late to get into AI right now … That the...Weiss Ratings | SponsoredWill I be blacklisted?Porter Stansberry says a financial force bigger than 9/11 or COVID is already ripping through America — and mo...Porter & Company | SponsoredWhen your faith is put to the test, what will you do?Former CIA advisor Jim Rickards believes President Trump has just unlocked what the Bible foretold — a $150 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ImmunoGen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ImmunoGen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IMGN Stock Alerts